Buchumschlag

Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Margaret R. Jorgenson, Ethan Meyer, Glen E. Leverson, Jillian L. Descourouez, Christopher M. Saddler, Jeannina A. Smith, John P. Rice, Didier A. Mandelbrot, Jon S. Odorico
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Clinical Transplantation
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
von: Hanna L. Kleiboeker, et al.
Veröffentlicht: (2025)

De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care
von: Hanna L. Kleiboeker, et al.
Veröffentlicht: (2025)

Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
von: Abdallah Mughrabi, et al.
Veröffentlicht: (2026)

Contemporary Cytomegalovirus (CMV) Infections in Low‐Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D−/R−): Time to Reexamine Donor CMV Serostatus
von: Madeleine R. Heldman, et al.
Veröffentlicht: (2024)

Serum β2‐Microglobulin Predicts Time to Recovery of Delayed Graft Function in Kidney Transplant Recipients
von: Sandesh Parajuli, et al.
Veröffentlicht: (2024)

Cytomegalovirus (CMV) Serostatus Reassessment in CMV Seronegative Kidney Transplant Candidates
von: Ajmeet K. Pama‐Ghuman, et al.
Veröffentlicht: (2025)

Utilization of a CMV T Cell Immunity Assay to Guide Secondary Prophylaxis in Solid Organ Transplant Recipients
von: Christina Doligalski, et al.
Veröffentlicht: (2026)

Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
von: Suneri J. Amin, et al.
Veröffentlicht: (2025)

Chronic Antibiotic Prophylaxis to Prevent Recurrent Cholangitis in Liver Transplant Recipients
von: Florence Runyo, et al.
Veröffentlicht: (2025)

Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients
von: John‐Anthony Coppola, et al.
Veröffentlicht: (2025)

Infection Prevention and Surveillance in the Care of Australasian Solid‐Organ Transplant Recipients
von: Priya Garg, et al.
Veröffentlicht: (2025)

A Qualitative Study of Cytomegalovirus Awareness and Experience in Kidney Transplant Recipients
von: Afolarin A. Otunla, et al.
Veröffentlicht: (2026)

Debates in Management and Treatment of CMV in Pediatric Solid Organ Transplant Recipients: A Case‐Based Discussion
von: Kevin J. Downes, et al.
Veröffentlicht: (2025)

What Would You Choose? Oral CMV Prophylaxis in Maintenance Hemodialysis Patients After Solid Organ Transplantation
von: Hidemasa Akazawa, et al.
Veröffentlicht: (2025)

Disparities in Access to Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk African American Kidney Transplant Patients
von: Shipra R. Bethi, et al.
Veröffentlicht: (2024)

Prolonged Trimethoprim–Sulfametoxazole Prophylaxis in Kidney Transplant Recipients: Is it Justified by the “Collateral Benefits”?
von: Belén Gutierrez‐Gutierrez, et al.
Veröffentlicht: (2025)

Genetic and Functional Evaluation of the Complement System in De Novo Thrombotic Microangiopathy After Transplantation: A Single‐Center Experience
von: Adam Bregman, et al.
Veröffentlicht: (2025)

Resistant/Refractory Cytomegalovirus Retinitis in Solid Organ and Hematopoietic Stem Cell Transplant Recipients: The Cause‐or‐Consequence Dilemma
von: Renato Pascale, et al.
Veröffentlicht: (2026)

Addressing the Rising Burden of Carbapenemase‐Producing Enterobacterales in Liver Transplant Recipients: A Call for Enhanced Surveillance and Prevention Strategies
von: Muna A. Al‐Maslamani, et al.
Veröffentlicht: (2025)

International Survey on Antibiotic Prophylaxis Approaches for Solid Organ Transplant Recipients and Donors Colonized With Multidrug‐Resistant Organisms
von: Julia Bini Viotti, et al.
Veröffentlicht: (2025)

Kidney Allograft Outcomes of Dual‐Organ Heart Kidney Transplant Recipients Following Donation After Circulatory Determination of Death
von: Ananya Gorrai, et al.
Veröffentlicht: (2026)

Updates on Vaccine‐Preventable Respiratory Viral Infections in Pediatric Solid Organ Transplant Recipients
von: Sanya J. Thomas, et al.
Veröffentlicht: (2025)

Persisting Gaps in Cytomegalovirus Prevention and Management After Solid Organ Transplantation in a Resource‐Limited Setting
von: Guilherme Santoro‐Lopes, et al.
Veröffentlicht: (2025)

Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
von: Lemuel R. Non, et al.
Veröffentlicht: (2024)

Transmission of Ehrlichia chaffeensis From an Organ Donor to a Kidney–Pancreas Transplant Recipient
von: Praveen Gundelly, et al.
Veröffentlicht: (2025)

Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
von: Vaisak O. Nair, et al.
Veröffentlicht: (2025)

Performance of Donor‐Derived Cell‐Free DNA in Surveillance and For‐Cause Biopsies in Pediatric Kidney Transplant Recipients
von: Stella Kilduff, et al.
Veröffentlicht: (2025)

Outcomes of Invasive Aspergillosis in Liver Transplant Recipients From an Institution Using Targeted Antifungal Prophylaxis and an Antifungal Stewardship Program
von: Brennan Collis, et al.
Veröffentlicht: (2025)

Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ Transplants
von: Kevin D. He, et al.
Veröffentlicht: (2024)

A Matched Case‐Control Study to Evaluate Predicted Drug Exposures and Neutropenia during Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients
von: Mai‐Uyen T. Nguyen, et al.
Veröffentlicht: (2025)

Cancer in Organ Recipients With Metastatic Spread to Transplant Organs: A Systematic Review
von: Claire Ma, et al.
Veröffentlicht: (2026)

Efficacy of a Single Dose of Intravesical Aminoglycoside for the Prevention of Urinary Tract Infections in Kidney Transplant Recipients
von: Sarah Dean, et al.
Veröffentlicht: (2026)

Association Between Liver Graft to Recipient Weight Ratio and Acute Kidney Injury Following Liver Transplantation: A Historical Cohort Study
von: Maxime Soucy‐Proulx, et al.
Veröffentlicht: (2024)

Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study
von: Estela Giménez, et al.
Veröffentlicht: (2025)

Risk of Cytomegalovirus Viremia Following Transplantation of Hepatitis C‐Viremic Donor Kidneys Into Uninfected Recipients: A Multi‐Center Retrospective Cohort Study
von: Vishnu S. Potluri, et al.
Veröffentlicht: (2025)

Cytomegalovirus‐Induced Arterial Intimal Fibrosis in the Kidney Transplant
von: Anukul Ghimire, et al.
Veröffentlicht: (2025)

Oxalate Nephropathy After Kidney Transplantation: Risk Factors and Outcomes of Two Phenotypes
von: Neetika Garg, et al.
Veröffentlicht: (2024)

Early clearance of BK polyomavirus‐DNAemia among kidney transplant recipients may lead to better graft survival
von: Isabel Breyer, et al.
Veröffentlicht: (2024)

Clinically Significant EBV Infection in Allogeneic Stem Cell Transplanted Children Receiving Letermovir as Primary CMV Prophylaxis
von: Christina Oikonomopoulou, et al.
Veröffentlicht: (2025)

Food Insecurity in Pediatric Kidney Transplant Recipients
von: Priya S. Verghese, et al.
Veröffentlicht: (2025)